OCT Group
Россия | |
http://www.oct-clinicaltrials.com | |
78124498634 | |
О компании Russia and Eastern Europe is one of the most attractive regions to conduct clinical trials. There are several advantages to place clinical trials in this area: Population size, providing access to a large potential pool of mostly treatment naive clinical trial subjects: Russia 142.2 million Ukraine 46.6 million Bulgaria 7.7 million Lithuania 3.4 million Latvia 2.3 million Estonia 1.3 million Belarus 10 million Total 213.5 million Centralized healthcare system with the developed referral network and a number of private practices. As a result - few sites needed to get a large number of patients Good selection of high-quality investigational sites ICH-GCP compliance principles incorporated into legislation High recruitment rates with low drop-out rates: Patient recruitment rates in the region is up to 10 times higher than in US and EU Savings in costs: Average cost per patient in Eastern Europe is 28lower than in Western Europe and 47than in the UK Possibility to reduce clinical trial expenditure by using local CROs and labs High level of qualification of investigators for conducting clinical trials. As a result – high quality clinical trial data |